UK 00:04 Saturday, 19 September 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
As noted back in November, I am a fan of Tate & Lyle (TATE) shares so it is pleasing to see them up 8% odd year-to-date. There are a bunch of reasons for this as I observed nearly five months ago, but the news today is that it’s buying a “leading prebiotic dietary fibre business in China from ChemPartner Pharmatech Co., Ltd for a total consideration of US$237 million”. It is far from a boring thing to do, in fact – for a company which is outsourcing the management of much of its core historic business shortly – it is actually quite interesting to help it access more of the Asian/emerging market world over time. I remain a fan. And what also about James Halstead (JHD), “the AIM listed manufacturer and international distributor of commercial floor coverings”, whose shares are most certainly not up year-to-date?
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
